BioTE AI Market Strategy Report - TRT Clinics

Answer Capsule

BioTE holds almost no recommendation power in the TRT Clinics category. In September 2026, the brand appeared in 5.05% of qualified AI answers but received only 1 valid recommendation across 218 qualified observations, a valid recommendation coverage of 0.46%. The clearest win is a single top-ten placement on Google AI Overviews. The clearest weakness is that BioTE is mentioned almost entirely as neutral context rather than as a recommended provider. The clearest opportunity is converting its existing presence in "best TRT clinics" prompts into actual shortlist placement.

Who This Report Is For

This report is for BioTE's marketing, growth, and clinical leadership teams, and for category strategists tracking how AI systems recommend testosterone therapy providers during early buyer research.

Report Card

Executive Summary

BioTE is visible in the TRT Clinics category but is not being recommended. Across 218 qualified observations in September 2026, the brand appeared in 11 answers, a raw mention presence rate of 5.05%, yet received only 1 valid recommendation, a valid recommendation coverage of 0.46%. That gap between presence and recommendation is the defining feature of BioTE's position in the benchmark.

The mention mix is heavily neutral. Of BioTE's 11 mentions, 10 were neutral and 1 was positive, producing a net sentiment score of 0.09. No negative mentions were recorded. The brand is being referenced as context, not endorsed as a provider.

BioTE's strongest cluster is the only qualified cluster in the public benchmark, "Best TRT Clinics & Top Testosterone Therapy Providers," where all of its measurable activity sits. Its strongest platform signal is Google AI Overviews, where it recorded 8 mentions, 1 positive mention, and its single valid recommendation. Every other platform tracked in the benchmark returned zero BioTE mentions.

The clearest gap is recommendation conversion. BioTE's presence rate of 5.05% is roughly one-tenth of category leader Hone Health's 77.06%, and its valid recommendation coverage of 0.46% is roughly one-ninetieth of Hone Health's 42.66%. Even smaller competitors such as Renew Vitality (2.29% coverage) and Low T Center (1.38% coverage) convert more of their presence into recommendations than BioTE does.

BioTE also has no rank-one placements and no top-three placements in the September 2026 data. Its single valid recommendation landed outside the top three, at an average recommended rank of 5. The brand is not competing for the first recommendation in any observed answer.

The pattern suggests BioTE is retrievable but not shortlistable. AI systems appear to know the brand exists and can place it in a list, but they are not treating it as a provider worth recommending when a buyer asks for the best TRT clinic.

What BioTE Is Winning

Questions This Section Answers

• Where does BioTE actually register in AI answers?
• Is BioTE being criticized or cautioned against in AI responses?

BioTE's wins in this benchmark are narrow but real.

The brand has a measurable presence on Google AI Overviews, the highest-volume surface in the dataset with 94 qualified observations. BioTE appeared in 8 of those, a raw mention presence rate of 8.51% on that surface, and captured its single valid recommendation there. That is the only platform where BioTE registers at all.

BioTE also recorded zero negative mentions across the entire benchmark. Its framing is neutral-to-positive, with 10 neutral mentions and 1 positive mention. The brand is not being criticized or cautioned against in AI answers.

Beyond those two points, the win column is thin. BioTE has no top-three placements, no rank-one placements, and no presence on ChatGPT, Copilot, Gemini, Perplexity, or AI Mode in the September 2026 data. The brand is essentially a single-surface presence in a six-surface category.

Where BioTE Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Why does BioTE get mentioned at a similar rate to Renew Vitality and Low T Center but recommended far less often?
• Which AI platforms return zero BioTE mentions?
• How far behind is BioTE on top-three and rank-one placements?

BioTE's clearest gap is recommendation conversion, not raw visibility. The brand appears in 5.05% of qualified answers but is recommended in only 0.46% of them. That is a conversion ratio of roughly one recommendation for every eleven mentions, and it places BioTE near the bottom of the tracked set on recommendation-weighted visibility.

The gap is most visible when compared to brands with similar or smaller presence. Renew Vitality appears in 5.96% of answers, only slightly more than BioTE, but converts that into 2.29% valid recommendation coverage, roughly five times BioTE's rate. Low T Center appears in 6.88% of answers and converts to 1.38% coverage, roughly three times BioTE's rate. BioTE is being mentioned at a comparable rate to these brands but is not being chosen at a comparable rate.

The second gap is platform concentration. BioTE has zero mentions on ChatGPT, Copilot, Gemini, Perplexity, and AI Mode. On ChatGPT, where Hone Health appears in 83.33% of answers and Defy Medical in 66.67%, BioTE is absent. On Copilot, where Hone Health appears in 96.55% of answers, BioTE is absent. The brand's entire AI footprint in this benchmark sits on Google AI Overviews.

The third gap is placement. BioTE has no top-three placements and no rank-one placements. Even its single valid recommendation landed at rank 5. In a category where Maximus holds a 9.63% rank-one rate and Hone Health holds an 8.26% rank-one rate, BioTE is not competing for the first recommendation position at all.

Biggest Opportunity

BioTE's biggest opportunity is converting its existing Google AI Overviews presence into shortlist placement. The brand already appears in 8.51% of AI Overviews answers, which means AI systems can retrieve and reference it. The problem is that those references are neutral context rather than recommendations.

The path forward is to strengthen the public evidence layer around BioTE's clinical positioning, particularly the bioidentical hormone therapy angle that distinguishes it from conventional TRT clinics, so that AI systems have a clear reason to move the brand from "mentioned" to "recommended." That means owned pages, third-party citations, and comparison-ready content that answers the specific question AI systems are trying to resolve: which TRT clinic should a buyer choose.

Competitive Landscape

Questions This Section Answers

• Where does BioTE sit relative to Hone Health, Defy Medical, and Maximus on recommendation-stage metrics?
• How does BioTE's net sentiment compare to other tracked TRT clinics?

Hone Health and Defy Medical hold the strongest recommendation-stage positions in the TRT Clinics category, with Hone Health leading on top-three rate and Defy Medical leading on net sentiment. BioTE sits near the bottom of the tracked set, with the lowest top-three rate among brands that received any recommendation credit.

Average recommended rank covers rank-eligible recommendations only.

BioTE's position at the bottom of the table reflects a brand that is present in the category conversation but not competitive in it. Its 0.00% top-three rate and 0.00% rank-one rate place it alongside Craft Concierge, the only other brand with no top-three placements, and its net sentiment of 0.0909 is the lowest among all tracked brands.

Prompt Evidence

Google AI Overviews / Best TRT Clinics & Top Testosterone Therapy Providers Prompt: "best testosterone replacement therapy" Result: BioTE appeared in the answer as a neutral reference but was not included in the recommendation shortlist.

Google AI Overviews / Best TRT Clinics & Top Testosterone Therapy Providers Prompt: "online doctors that prescribe testosterone" Result: BioTE was mentioned alongside other providers but received no recommendation credit.

Google AI Overviews / Best TRT Clinics & Top Testosterone Therapy Providers Prompt: "trt clinic" Result: BioTE appeared in the response as context, with the recommendation going to higher-coverage brands.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map every prompt where BioTE appears, every prompt where it is absent, and the exact language AI systems use when they mention the brand without recommending it.

Phase 2: Recommendation Readiness Plan Identify the specific evidence gaps that keep BioTE in neutral-reference territory, starting with the Google AI Overviews surface where the brand already has presence.

Phase 3: Owned Answer Layer Buildout Build BioTE-owned pages that directly answer the questions AI systems are resolving, including provider comparisons, clinical positioning, and treatment-option explanations.

Phase 4: Citation / Authority Layer Development Strengthen the third-party source footprint that AI systems retrieve from, so BioTE's clinical differentiation is visible in the public evidence layer.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track whether BioTE's presence converts into recommendation credit month over month, and whether the brand expands beyond Google AI Overviews onto ChatGPT, Copilot, Gemini, Perplexity, and AI Mode.

Why This Matters

AI systems are now where a large share of TRT buyers form their shortlist. When a buyer asks which clinic to choose, the answer they receive is the answer they act on. BioTE is currently visible in that conversation but not recommended in it, which means the brand is being seen without being chosen.

Presence alone does not move a buyer. A neutral mention in an AI answer does not create a shortlist slot. The next move for BioTE is targeted correction of the prompt, page, and citation layers that determine whether AI systems treat the brand as a provider worth recommending or as background context.

Core Metrics

Sentiment Score

Questions This Section Answers

• Why is BioTE's 5.05% mention presence misleading without looking at sentiment?
• What does BioTE's net sentiment score of 0.0909 tell buyers and brands about its AI visibility?

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For BioTE in September 2026: (1 × 1 + 10 × 0 + 0 × -1) / 11 = 0.0909.

This score matters because unclassified mention counts are misleading. A brand that appears in 11 answers sounds visible until you separate those mentions into positive recommendations, neutral references, and cautionary notes. BioTE's 11 mentions are almost entirely neutral, which means the brand is being named without being endorsed.

Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal in value. Counting all mentions as wins is bad measurement. Classified sentiment is required before interpreting AI visibility, and BioTE's classified sentiment shows a brand that is present but not preferred.

Sentiment by Platform

Methodology

1. This report is a benchmark-based analysis of BioTE's position in the TRT Clinics category, using the LLM Authority Index AI Market Discovery Index for September 2026.
2. The reporting window is September 2026, with comparison points to July 2026 and August 2026 where the benchmark provides them.
3. Six AI and search surface families were tracked: ChatGPT, Copilot, Gemini, Perplexity, Google AI Overviews, and Google AI Mode.
4. The September 2026 benchmark produced 218 qualified observations after qualification, drawn from 800 source prompt-surface observations.
5. The competitor universe includes 10 tracked brands: BioTE, Craft Concierge, Defy Medical, Fountain TRT, Henry Meds, Hone Health, Low T Center, Marek Health, Maximus, and Renew Vitality.
6. One qualified public cluster was used: "Best TRT Clinics & Top Testosterone Therapy Providers," which falls into the consideration stage of the buyer journey.
7. Stage 0 extraction retained the query, AI surface, answer, brand outcome, recommendation placement, sentiment, and citations where exposed.
8. A mention is counted when a tracked brand appears in a qualified observation, regardless of whether it is recommended.
9. A valid recommendation is counted when a brand receives a clear, actionable recommendation in a qualified observation. Neutral references, comparison anchors, and listed-only mentions are not counted as valid recommendations.
10. Brand-level percentages use the 218 qualified observations as the public denominator, not the 800 raw prompt-surface observations.
11. The public benchmark does not contain qualified observations in the Pricing & Value or Multi-Brand Comparison clusters, so this report cannot speak to how BioTE performs in pricing or head-to-head comparison prompts.
12. Small-count brands such as BioTE operate on very few valid recommendations, so a change of one or two answers moves their percentages materially. BioTE's single valid recommendation should be read with that base in mind.

See Where AI Is Recommending Your Brand

The public benchmark shows where BioTE stands in the TRT Clinics category. A company-level AI visibility audit shows why, mapping the specific prompts where BioTE is mentioned without being recommended, the competitors capturing those recommendations, and the evidence gaps that need attention.